(Q36860946)

16 August 2017

1 reference

title

New approaches to the treatment of dense deposit disease (English)

1 reference

16 August 2017

4

Marina Botto

0 references

Matthew C Pickering

Matthew C Pickering

17

0 references

David J Salant

David J Salant

20

0 references

Johan Van Der Vlag

Johan van der Vlag

Santiago Rodriguez de Córdoba

25

0 references

Santiago Rodriguez de Córdoba

7

0 references

John D. Lambris

John D Lambris

11

0 references

Peter F Zipfel

28

Peter F Zipfel

1 reference

16 August 2017

27

Reinhard Würzner

1 reference

16 August 2017

3

Paul N Barlow

1 reference

16 August 2017

Richard J H Smith

1

1 reference

16 August 2017

Jessy Alexander

2

1 reference

16 August 2017

Marina Botto

4

1 reference

16 August 2017

Thomas L Cassavant

5

1 reference

16 August 2017

H Terence Cook

6

1 reference

16 August 2017

Gregory S Hageman

8

1 reference

16 August 2017

T Sakari Jokiranta

9

1 reference

16 August 2017

William J Kimberling

10

1 reference

16 August 2017

Lynne D Lanning

12

1 reference

16 August 2017

Vicki Levidiotis

13

1 reference

16 August 2017

Christoph Licht

14

1 reference

16 August 2017

Hans U Lutz

15

1 reference

16 August 2017

Seppo Meri

16

1 reference

16 August 2017

Richard J Quigg

18

1 reference

16 August 2017

Angelique L Rops

19

1 reference

16 August 2017

Sanjeev Sethi

21

1 reference

16 August 2017

Joshua M Thurman

22

1 reference

16 August 2017

Hope F Tully

23

1 reference

16 August 2017

Sean P Tully

24

1 reference

16 August 2017

Patrick D Walker

26

1 reference

16 August 2017

Dense Deposit Disease Focus Group

29

1 reference

16 August 2017

5 August 2007

1 reference

Journal of the American Society of Nephrology

16 August 2017

1 reference

16 August 2017

18

1 reference

16 August 2017

9

1 reference

16 August 2017

2447-2456

1 reference

Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Dense deposit disease is not a membranoproliferative glomerulonephritis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Heparan sulfate on activated glomerular endothelial cells and exogenous heparinoids influence the rolling and adhesion of leucocytes.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Drug insight: rituximab in renal disease and transplantation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

A journey of hope: lessons learned from studies on rare diseases and orphan drugs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Drugs for exceptionally rare diseases: do they deserve special status for funding?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Complement amplification revisited

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Membranoproliferative glomerulonephritis type II (dense deposit disease): an update

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Pathogenesis of lesions in late age-related macular disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Heparan sulfate proteoglycans in glomerular inflammation.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

HMG-CoA reductase inhibitors for the prevention of nephropathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Hyperlipidemia and thrombotic complications in patients with membranous nephropathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease")

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Rare diseases and the assessment of intervention: what sorts of clinical trials can we use?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Clinical trials and rare diseases: a way out of a conundrum

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Genetically determined variation in the complement system: relationship to disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Genetic polymorphism of the third component of human complement (C'3).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha-chain of the complement component, C3.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Idiopathic membranoproliferative glomerulonephritis in childhood

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Dense deposit disease: a variant of membranoproliferative glomerulonephritis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Genetic polymorphism of C3 and Bf in IgA nephropathy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Molecular basis of polymorphisms of human complement component C3.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone--a report of the International Study of Kidney Disease in Children

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

A descriptive study of individuals with membranoproliferative glomerulonephritis.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

A study on the safety, efficacy, and efficiency of sulodexide compared with acenocoumarol in secondary prophylaxis in patients with deep venous thrombosis

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Management of membranoproliferative glomerulonephritis type II with plasmapheresis.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

4 September 2018

The Nephrotic Syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Membranoproliferative glomerulonephritis: improved survival with alternate day prednisone therapy.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Increasing efficiency in evaluation research: the use of sequential analysis.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H

4 September 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

20 October 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4853920

Regression of Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease): Observations in Six Children

4 December 2018

1 reference

12 December 2020

Molecular analysis of C3 allotypes in patients with systemic vasculitis

1 reference

12 December 2020

Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS)

1 reference

12 December 2020

Renal transplantation in patients with dense deposit disease: morphological characteristics of recurrent disease and clinical outcome

1 reference

12 December 2020

Porcine membranoproliferative glomerulonephritis with intramembranous dense deposits (porcine dense deposit disease)

1 reference

12 December 2020

A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis

1 reference

12 December 2020

Molecular analysis of C3 allotypes in patients with nephritic factor

1 reference

12 December 2020

Pharmacological actions of sulodexide

1 reference

12 December 2020

Results of a controlled drug trial in membranoproliferative glomerulonephritis

1 reference

12 December 2020

Acute non-proliferative glomerulitis: a cause of renal failure unique to children

1 reference

12 December 2020

Complement analysis in children with idiopathic membranoproliferative glomerulonephritis: a long-term follow-up

1 reference

12 December 2020

The distribution of C 3 types in Norway

1 reference

12 December 2020

Heparanase activity is dysregulated in children with steroid-sensitive nephrotic syndrome

1 reference

12 December 2020

Inhibition of Terminal Complement Complex Formation and Cell Lysis by Monoclonal Antibodies

1 reference

12 December 2020

Formation of high-affinity C5 convertases of the alternative pathway of complement

1 reference

12 December 2020

Report 1973-1974 of the Reference Laboratory for the polymorphism of the third component (C3) of the human complement system

1 reference

12 December 2020

Increased expression of heparanase in overt diabetic nephropathy

1 reference

12 December 2020

Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation

1 reference

12 December 2020

Identifiers

DOI

10.1681/ASN.2007030356

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

17675665

1 reference